Institutional Ownership
Resmed Inc
CUSIP 761152107COMRMDQ1 2026
Latest EPS (Diluted)
$2.74
Q1 2026 · Mar 31, 2026
Latest Revenue
$1.43B
Reported quarter
Latest Net Income
$398.73M
Reported quarter
Quarters on Record
12
From SEC XBRL filings
Quarterly Earnings
EPS, revenue & net income · SEC XBRL (10-Q / 10-K)
| Period | Quarter | EPS (Basic) | EPS (Diluted) | Revenue | Net Income | Form |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Q1 2026 | $2.74 | $2.74 | $1.43B | $398.73M | 10-Q |
| Dec 31, 2025 | Q4 2025 | $2.69 | $2.68 | $1.42B | $392.59M | 10-Q |
| Sep 30, 2025 | Q3 2025 | $2.38 | $2.37 | $1.34B | $348.54M | 10-Q |
| Mar 31, 2025 | Q1 2025 | $2.49 | $2.48 | $1.29B | $365.04M | 10-Q |
| Dec 31, 2024 | Q4 2024 | $2.35 | $2.34 | $1.28B | $344.62M | 10-Q |
| Sep 30, 2024 | Q3 2024 | $2.12 | $2.11 | $1.22B | $311.36M | 10-Q |
| Mar 31, 2024 | Q1 2024 | $2.04 | $2.04 | $1.20B | $300.49M | 10-Q |
| Dec 31, 2023 | Q4 2023 | $1.42 | $1.42 | $1.16B | $208.80M | 10-Q |
| Sep 30, 2023 | Q3 2023 | $1.49 | $1.49 | $1.10B | $219.42M | 10-Q |
| Mar 31, 2023 | Q1 2023 | $1.58 | $1.58 | $1.12B | $232.50M | 10-Q |
| Dec 31, 2022 | Q4 2022 | $1.53 | $1.53 | $1.03B | $224.91M | 10-Q |
| Sep 30, 2022 | Q3 2022 | $1.44 | $1.43 | $950.29M | $210.48M | 10-Q |